NovaCina
Chanbasha Shaik currently serves as the Head of Global Pharmacovigilance at LumaCina - Bridgewest Perth Pharma since January 2024. Prior to this role, Chanbasha was the Associate Director of Pharmacovigilance at Voisin Consulting Life Sciences from October 2021 to January 2024. Experience in clinical development and pharmacovigilance included a position as Pharmacovigilance Manager at Biocon Biologics and as Pharmacovigilance Scientist at AstraZeneca from March 2016 to September 2020. Earlier professional roles featured Therapeutic Area Lead and Clinical Safety Scientist at Accenture Services Pvt Ltd, and various positions at Mahindra Satyam and DATA MONITOR. Chanbasha Shaik holds a Master of Pharmacy in Pharmacology from Rajiv Gandhi University of Health Sciences.
This person is not in the org chart
This person is not in any offices
NovaCina
2 followers
NovaCina is a leading supplier of sterile liquid pharmaceutical contract manufacturing services. From early-stage drug development to full-scale manufacturing, to advanced analytical studies, we have the capabilities to support you in delivering products of the highest quality to market.